Project Grant HT94252410964
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
The Defense Health Agency awarded a $1,000,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to support research on the "Diversity of Memory B Cells in Lupus". The 4-year grant, with a period of performance from September 1, 2024 to August 31, 2028, will enable Boston Children's Hospital to conduct biomedical research focused on understanding the role of...
This $462,131 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports transformative behavioral health research to improve quality of life for individuals with childhood-onset lupus. The prime awardee, The Hospital for Sick Children (Sick Kids Hospital) in Toronto, Canada, will lead this 4-year initiative. As a leading pediatric research hospital, Sick Kids Hospital has extensive experience as a subcontractor on...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $249,999.00 to the Children's Hospital Medical Center in Cincinnati, Ohio to conduct an "Assessment of Smoldering Glial Activation in Pediatric-Onset MS by Novel Neuroimaging" research project. The 2-year grant period runs from September 15, 2025 to September 14, 2027. As a leading pediatric medical research institution, Children's Hospital...
The Department of Defense's Military Medical Research and Development (CFDA 12.420) program awarded a $300,000 Project Grant to Duke University to investigate the "Complement-Activating Properties of Anti-Sm/RNP Antibodies in SLE". This 2-year research effort, starting on September 1, 2024 and ending on August 31, 2026, aims to advance biomedical research that can transform healthcare for military service members, veterans, and the broader public. The Military Medical Research and...
This $1,561,794 Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research led by the University of Cincinnati to investigate the role of plasmacytoid dendritic cells (pDCs) in immune suppression and treatment resistance in acute myeloid leukemia. The award will fund a 3-year research project from September 2024 through August 2027 to advance the scientific understanding of how pDCs...
This $1,354,428 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a family-centered e-health intervention to promote patient and caregiver well-being in adolescent and emerging adult pediatric brain tumor survivors. The grant was awarded to the Children's Hospital Medical Center in Cincinnati, Ohio, which will serve as the prime awardee. The project duration is from September 1, 2024 to August 31, 2028. The...
The federal Project Grant award of $624,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award, with a performance period from September 1, 2025, to August 31, 2027, will fund a comprehensive in vivo phenotyping study of fusion-driven pediatric rhabdomyosarcomas conducted by the...
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...
The federal Project Grant award, totaling $999,972.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Feinstein Institutes For Medical Research. The grant supports a study focused on "Studying Urine Macrophages in Lupus Nephritis to Shed Light on Kidney Disease Processes." The research aims to advance the understanding of lupus nephritis, a serious kidney condition, by examining immune cells in urine samples....